Advances in the Use of Nanoparticles for Vaccine Platform Development: 2nd Edition
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Adjuvants".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 58
Special Issue Editor
Interests: drug delivery; polymer and lipid based nanocarrier delivery systems; pulmonary drug delivery; biopharmaceuticals and vaccines delivery systems for human and veterinary use
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vaccination is effective in preventing diseases worldwide. Over the years, new vaccine candidates have been developed, including nucleic acids and subunit vaccines, that incorporate only specific components of pathogens. These innovations have led to vaccines that induce specific immune responses with fewer side effects. However, newer-generation vaccines sometimes show lower immunogenicity. To address this, nanoparticle-based formulations—such as polymeric nanoparticles, virosomes, and lipid nanoparticles—enhance the induction of robust immune responses. These nanoparticle delivery systems protect vaccine candidates, improve their stability, prevent degradation, and have adjuvant properties that enhance immunogenicity. They effectively target antigen-presenting cells (APCs) and can elicit innate, humoral, cellular, or mucosal immune responses, with the flexibility for various administration routes. As research on nanoparticle-based vaccines progresses, reproducible and scalable manufacturing methods are also advancing.
This Special Issue invites original research and review articles focusing on the preclinical and clinical development of advanced nanoparticle delivery systems. These may include liposomes; lipid-based, polymeric, gold, inorganic, and biomimetic nanoparticles; virus-like particles; self-assembled proteins; and other forms, including carbon-based nanoparticles such as carbon nanotubes and graphene.
Prof. Dr. Imran Saleem
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- vaccine
- immunotherapy
- subunit vaccine
- RNA vaccine
- adjuvant
- nanotechnology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
